Dietary lipids and their oxidized products in Alzheimer's disease
โ Scribed by Laura Corsinovi; Fiorella Biasi; Giuseppe Poli; Gabriella Leonarduzzi; Gianluca Isaia
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 239 KB
- Volume
- 55
- Category
- Article
- ISSN
- 1613-4125
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
Alzheimer's disease (AD) is the commonest form of dementia in the elderly, characterized by memory dysfunction, loss of lexical access, spatial and temporal disorientation, and impaired judgment. A growing body of scientific literature addresses the implication of dietary habits in the pathogenesis of AD. This review reports recent findings concerning the modulation of AD development by dietary lipids, in animals and humans, focusing on the pathogenetic role of lipid oxidation products. Oxidative breakdown products of ฯโ6 polyunsaturated fatty acids (ฯโ6 PUFAs), and cholesterol oxidation products (oxysterols), might play a role in favoring ฮฒโamyloid deposition, a hallmark of AD's onset and progression. Conversely, ฯโ3 PUFAs appear to contribute to preventing and treating AD. However, high concentrations of ฯโ3 PUFAs can also produce oxidized derivatives reacting with important functions of nervous cells. Thus, altered balances between cholesterol and oxysterols, and between ฯโ3 and ฯโ6 PUFAs must be considered in AD's pathophysiology. The use of a diet with an appropriate ฯโ3/ฯโ6 PUFA ratio, rich in healthy oils, fish and antioxidants, such as flavonoids, but low in cholesterolโcontaining foods, can be a beneficial component in the clinical strategies of prevention of AD.
๐ SIMILAR VOLUMES
## Abstract ## Objective The APOE epsilonโ4 allele has consistently emerged as a susceptibility factor for Alzheimer's disease (AD). Proโinflammatory cytokines are detectable at abnormal levels in AD, and are thought to play a pathophysiological role. Animal studies have shown doseโdependent corre